• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Critical, Emergent and Pulmonary Care Classics

STOP-IT Trial: Fixed-Duration Antibiotic Therapy for Intraabdominal Infections [Classics Series]

byTomi JunandMatthew Growdon
August 27, 2025
in Critical, Emergent and Pulmonary Care Classics, Infectious Disease Classics, Surgery Classics, The Classics
Reading Time: 5 mins read
0
Share on FacebookShare on Twitter

1. The STOP-IT trial found that 4 days of fixed antibiotic therapy after surgical or percutaneous source control is as effective as a longer, symptom-guided course for patients with complicated intraabdominal infections.

2. These findings support antibiotic stewardship, reducing unnecessary antibiotic exposure without compromising patient safety.

Evidence Rating Level: 1 (Excellent)      

Find more landmark study summaries like this in the book 2 Minute Medicine’s The Classics in Medicine: Summaries of the Landmark Trials, 2e (The Classics Series).

Study Rundown: The STOP-IT trial (Strategies to Optimize the Duration of Prophylaxis in Intraabdominal Infection Therapy) was a landmark randomized controlled trial that challenged the longstanding practice of tailoring antibiotic duration to clinical resolution of fever, leukocytosis, and ileus.

Traditionally, clinicians often extended antibiotic therapy for 7–10 days or longer until overt signs of infection resolved. This approach, however, contributes to antimicrobial resistance, adverse events, and higher healthcare costs. The STOP-IT trial instead tested whether a short, fixed course of 4 days would provide equivalent protection against post-surgical infectious complications.

RELATED REPORTS

Risk of bloodstream infections with indwelling peripheral catheters increase after 3 days

#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections

The 2 Minute Medicine Podcast Episode 54

Among 518 adults with complicated intraabdominal infections who achieved adequate source control, the trial found no difference in the rate of surgical site infections, recurrent intraabdominal infections, or death between the fixed-duration and symptom-guided groups.

Click to read the study, published today in NEJM

Relevant Reading: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial

In-Depth [randomized controlled trial]:  The STOP-IT trial was a multicenter, open-label randomized controlled trial conducted across 23 hospitals in the United States between 2008 and 2013. Eligible participants were adults with complicated intraabdominal infections who had undergone successful surgical or percutaneous source control. Patients with inadequate source control, severe immunocompromise, or uncontrolled sepsis were excluded to ensure safety and generalizability.

Study Design and Interventions

A total of 518 patients were randomized into two groups:

  1. Fixed-duration group: Received antibiotics for exactly 4 calendar days after source control, regardless of symptoms.

  2. Control group (traditional therapy): Continued antibiotics until at least 2 days after clinical signs of infection resolved — specifically, fever, elevated white blood cell count, or ileus. The median duration in this group was 8 days (IQR 5–10 days).

All patients received standard broad-spectrum antibiotic therapy, chosen at the discretion of treating physicians, consistent with IDSA guidelines at the time.

Outcomes and Results

The primary endpoint was a composite outcome of surgical site infection, recurrent intraabdominal infection, or death within 30 days of source control.

  • In the fixed-duration group, 21.8% of patients experienced the composite outcome.

  • In the traditional group, 22.3% of patients experienced the same outcome.

  • This difference was not statistically significant, demonstrating non-inferiority of the shorter course.

Secondary outcomes, including length of hospital stay, incidence of Clostridioides difficile infection, and rates of other healthcare-associated infections, were also similar between the two groups. Importantly, there was no evidence of harm from limiting antibiotic therapy to just 4 days.

Clinical Implications

The STOP-IT trial directly addressed a long-standing clinical debate: whether the duration of antibiotics for intraabdominal infections should be determined by patient recovery or by a fixed evidence-based protocol. The results provide strong evidence that longer is not necessarily better when it comes to antibiotic therapy.

By demonstrating that short-course therapy is equally effective, the STOP-IT trial supports modern antimicrobial stewardship strategies. Limiting unnecessary antibiotic exposure can:

  • Reduce the risk of antibiotic resistance

  • Decrease the risk of antibiotic-associated complications such as C. difficile colitis

  • Lower healthcare costs and shorten hospital stays

The trial has been widely cited in updated IDSA and Surgical Infection Society guidelines, which now endorse shorter, fixed-duration antibiotic courses following adequate source control.


STOP-IT Trial Summary Table

Feature Details
Population 518 adults with complicated intraabdominal infections after surgical or percutaneous source control
Intervention Fixed 4-day antibiotic course
Comparison Traditional therapy: median 8 days, continued until 2 days after symptom resolution
Primary Outcome Surgical site infection, recurrent intraabdominal infection, or death within 30 days
Results 21.8% (fixed duration) vs 22.3% (traditional); no difference
Conclusion Fixed 4-day antibiotic therapy is non-inferior to traditional longer courses

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antibiotics
Previous Post

Oral prednisone improves function, not pain in acute lumbar radiculopathy

Next Post

FDG-PET may guide antibiotic therapy in vascular graft infections

RelatedReports

Quick Take: Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG)
Hematology

Risk of bloodstream infections with indwelling peripheral catheters increase after 3 days

April 28, 2025
#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections
StudyGraphics

#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections

March 26, 2025
The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 54

March 21, 2025
Oral amoxicillin as effective as injectable benzylpenicillin-gentamicin for infants with infection in which referral not possible [AFRINEST Trial]
Infectious Disease

Seven days of antibiotic treatment non-inferior to 14 days for bloodstream infections

March 18, 2025
Next Post
FDG-PET may guide antibiotic therapy in vascular graft infections

FDG-PET may guide antibiotic therapy in vascular graft infections

Age not associated with differences in radiosurgical arteriovenous malformation outcomes

Age not associated with differences in radiosurgical arteriovenous malformation outcomes

Maternal verbal interaction more common than paternal during infancy

Single motherhood associated with poorer health outcomes in late adulthood

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • β-Blocker Use and Health Status Among Patients With Heart Failure With Preserved Ejection Fraction
  • Leqembi gains at home injection for maintenance dosing
  • Computed Tomographic Angiography and Yield for Gastrointestinal Bleeding in the Emergency Department
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.